Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan
As FMT from TEL-pretreated mice influences the microbiota in acceptor mice with slight weight-reducing effects, we confirm the relevance of TEL-related microbiota changes for weight reduction, most likely independent of the transferred stool-residual TEL effect on the host metabolism.
Authors
- Misa Hirose (ORCID: https://orcid.org/0000-0002-8909-4693)
- Axel Künstner
- Walter Raasch (ORCID: https://orcid.org/0000-0002-8781-2997)
- Ines Stölting
- M Freschi
- Hauke Busch (ORCID: https://orcid.org/0000-0003-4763-4521)
- Gianna Huber
Institutions
- Social Neuroscience Lab (DE)
- German Centre for Cardiovascular Research (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-18
- DOI
- https://doi.org/10.3389/fphar.2024.1453989
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Deutsche Forschungsgemeinschaft
- Universität zu Lübeck